Diabetic Retinopathy (DR)
Also known as: Retinopathy, Diabetic / Diabetic Retinopathy / Retinal abnormality - diabetes-related (disorder) / Retinal abnormality - diabetes-related / Diabetic retinopathy NOS (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetes + eye manifestation (& [cataract] or [retinopathy]) / Retinopathy diabetic / Diabetes with ophthalmic manifestations / Diabetes mellitus NOS with ophthalmic manifestation (disorder) / Disorder of eye due to diabetes mellitus (disorder) / Diabetic eye disease / Diabetic eye disease NOS / Diabetes mellitus with ophthalmic manifestation (disorder) / (Secondary cataract) or (diabetic cataract) / Diabetic cataract / Cataract diabetic / Cataract of eye due to diabetes mellitus (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB08885 | Aflibercept | A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy. |
DB01270 | Ranibizumab | A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. |